{
    "nct_id": "NCT05562791",
    "official_title": "Pilot Study of 68Gallium PSMA-PET/CT in Patients With Metastatic Urothelial Carcinoma or Melanoma",
    "inclusion_criteria": "Inclusion Criteria for Urothelial Carcinoma Cohort:\n\n* Patients with histologically confirmed metastatic urothelial carcinoma with extrapelvic nodal and/or visceral sites of disease (including lung, liver, bone, or soft tissue)\n* At least 3 lesions assessable by FDG PET/CT according to RECIST and PERCIST guidelines where applicable, that are determined suspicious for metastasis by an MSKCC attending radiologist or nuclear medicine physician.\n* Karnofsky performance status ≥50% (or ECOG/WHO ≤2)\n* Participant is ≥18 years of age\n* Patient must be able to understand and is willing to sign a written informed consent document\n\nInclusion Criteria for Melanoma Cohort:\n\n* Patients with histologically confirmed metastatic melanoma\n* At least 1 metastatic lesion assessable by CT or FDG PET/CT according to RECIST that is determined to be suspicious for metastasis by an MSKCC attending radiologist or nuclear medicine physician\n* ECOG <= 2\n* Participant is >= 18 years of age\n* Patient must be able to understand and is willing to sign a written informed consent document\n\nExclusion Criteria for Urothelial Carcinoma Cohort:\n\n* Patients with pelvic node-only metastatic disease. If the patient has lymph node only disease, at least one PET-assessable node must be located outside of the pelvis\n* Patients with bone only disease\n* Unable to lie flat, still, or to tolerate a PET scan\n* Patient undergoing active treatment for non-urothelial malignancy, other than skin basal cell or cutaneous superficial squamous cell carcinoma that has not metastasized.\n* Patients on a therapeutic clinical trial where PSMA imaging would interfere with the conduct of the trial\n* Patients undergoing active surveillance with a known history of non-urothelial malignancies\n* Women who are pregnant. All women of childbearing potential must have a documented negative pregnancy test.\n\nExclusion Criteria for Melanoma Cohort:\n\n* Unable to lie flat, still, or tolerate PET scan.\n* Patient is on another therapeutic trial where PSMA imaging would interfere with the conduct of the trial.\n* Women who are pregnant. All women of childbearing potential must have a documented negative pregnancy test.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}